Arkolith/Insider Trading/PLXP/Form 4

O'Connor Rita M

Chief Financial OfficerPLx Pharma Inc. (PLXP) · full profile →Form 4 · filed Mar 16, 2022
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 15, 2022Buy(P)10K$3.66$37K23K
Mar 15, 2022Buy(P)4K$3.65$14K27K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-22-000884) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML